nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR1B—schizophrenia	0.154	0.21	CbGaD
Ergotamine—HTR2C—schizophrenia	0.125	0.172	CbGaD
Ergotamine—HTR1A—schizophrenia	0.122	0.167	CbGaD
Ergotamine—DRD2—schizophrenia	0.103	0.141	CbGaD
Ergotamine—CYP1A2—schizophrenia	0.0945	0.129	CbGaD
Ergotamine—HTR2A—schizophrenia	0.0798	0.109	CbGaD
Ergotamine—ABCB1—schizophrenia	0.0521	0.0713	CbGaD
Ergotamine—SLC6A2—locus ceruleus—schizophrenia	0.00477	0.0547	CbGeAlD
Ergotamine—HTR2A—locus ceruleus—schizophrenia	0.00287	0.0329	CbGeAlD
Ergotamine—HTR1B—telencephalic ventricle—schizophrenia	0.00283	0.0324	CbGeAlD
Ergotamine—HTR1D—telencephalic ventricle—schizophrenia	0.00274	0.0314	CbGeAlD
Ergotamine—HTR2C—telencephalic ventricle—schizophrenia	0.00271	0.0311	CbGeAlD
Ergotamine—SLC6A2—autonomic nervous system—schizophrenia	0.00254	0.0291	CbGeAlD
Ergotamine—HTR2A—cerebellar cortex—schizophrenia	0.00234	0.0268	CbGeAlD
Ergotamine—HTR1A—telencephalic ventricle—schizophrenia	0.00228	0.0262	CbGeAlD
Ergotamine—DRD2—telencephalic ventricle—schizophrenia	0.00206	0.0236	CbGeAlD
Ergotamine—HTR1F—forebrain—schizophrenia	0.0018	0.0207	CbGeAlD
Ergotamine—HTR1F—telencephalon—schizophrenia	0.00166	0.019	CbGeAlD
Ergotamine—HTR2A—pons—schizophrenia	0.00165	0.0189	CbGeAlD
Ergotamine—CYP1A2—urine—schizophrenia	0.00159	0.0182	CbGeAlD
Ergotamine—HTR1E—forebrain—schizophrenia	0.00156	0.0179	CbGeAlD
Ergotamine—HTR2A—autonomic nervous system—schizophrenia	0.00152	0.0175	CbGeAlD
Ergotamine—HTR1E—telencephalon—schizophrenia	0.00144	0.0165	CbGeAlD
Ergotamine—HTR2A—telencephalic ventricle—schizophrenia	0.00136	0.0156	CbGeAlD
Ergotamine—HTR2A—urine—schizophrenia	0.00124	0.0142	CbGeAlD
Ergotamine—HTR2A—pineal body—schizophrenia	0.00118	0.0135	CbGeAlD
Ergotamine—CYP3A4—urine—schizophrenia	0.00115	0.0132	CbGeAlD
Ergotamine—HTR1A—blood plasma—schizophrenia	0.00109	0.0125	CbGeAlD
Ergotamine—HTR1F—nervous system—schizophrenia	0.000979	0.0112	CbGeAlD
Ergotamine—ADRA1D—forebrain—schizophrenia	0.000957	0.011	CbGeAlD
Ergotamine—HTR1F—central nervous system—schizophrenia	0.000942	0.0108	CbGeAlD
Ergotamine—ADRA1D—telencephalon—schizophrenia	0.00088	0.0101	CbGeAlD
Ergotamine—HTR1E—nervous system—schizophrenia	0.000848	0.00972	CbGeAlD
Ergotamine—CYP1A2—blood plasma—schizophrenia	0.000829	0.00951	CbGeAlD
Ergotamine—HTR1E—central nervous system—schizophrenia	0.000816	0.00936	CbGeAlD
Ergotamine—ADRA2A—blood plasma—schizophrenia	0.000763	0.00874	CbGeAlD
Ergotamine—HTR1F—brain—schizophrenia	0.000748	0.00857	CbGeAlD
Ergotamine—HTR1B—forebrain—schizophrenia	0.000739	0.00847	CbGeAlD
Ergotamine—HTR1D—forebrain—schizophrenia	0.000715	0.0082	CbGeAlD
Ergotamine—HTR2C—forebrain—schizophrenia	0.000708	0.00812	CbGeAlD
Ergotamine—HTR1B—telencephalon—schizophrenia	0.000679	0.00779	CbGeAlD
Ergotamine—Dihydroergotamine—HTR6—schizophrenia	0.000669	0.08	CrCbGaD
Ergotamine—HTR2B—forebrain—schizophrenia	0.000665	0.00763	CbGeAlD
Ergotamine—HTR1D—telencephalon—schizophrenia	0.000658	0.00754	CbGeAlD
Ergotamine—HTR2C—telencephalon—schizophrenia	0.000651	0.00746	CbGeAlD
Ergotamine—HTR2A—blood plasma—schizophrenia	0.000649	0.00743	CbGeAlD
Ergotamine—HTR1E—brain—schizophrenia	0.000648	0.00743	CbGeAlD
Ergotamine—HTR2B—telencephalon—schizophrenia	0.000612	0.00701	CbGeAlD
Ergotamine—CYP3A4—blood plasma—schizophrenia	0.0006	0.00688	CbGeAlD
Ergotamine—HTR1A—forebrain—schizophrenia	0.000596	0.00683	CbGeAlD
Ergotamine—SLC6A2—forebrain—schizophrenia	0.000591	0.00677	CbGeAlD
Ergotamine—ADRA1D—endocrine gland—schizophrenia	0.000555	0.00636	CbGeAlD
Ergotamine—ADRA1A—forebrain—schizophrenia	0.00055	0.0063	CbGeAlD
Ergotamine—HTR1A—telencephalon—schizophrenia	0.000548	0.00628	CbGeAlD
Ergotamine—SLC6A2—telencephalon—schizophrenia	0.000544	0.00623	CbGeAlD
Ergotamine—DRD2—forebrain—schizophrenia	0.000539	0.00617	CbGeAlD
Ergotamine—ADRA1B—nervous system—schizophrenia	0.000531	0.00609	CbGeAlD
Ergotamine—ADRA1D—nervous system—schizophrenia	0.000519	0.00595	CbGeAlD
Ergotamine—ADRA1B—central nervous system—schizophrenia	0.000511	0.00586	CbGeAlD
Ergotamine—ADRA1A—telencephalon—schizophrenia	0.000505	0.00579	CbGeAlD
Ergotamine—ADRA1D—central nervous system—schizophrenia	0.0005	0.00573	CbGeAlD
Ergotamine—DRD2—telencephalon—schizophrenia	0.000495	0.00568	CbGeAlD
Ergotamine—HTR1B—midbrain—schizophrenia	0.000488	0.00559	CbGeAlD
Ergotamine—Ergoloid mesylate—DRD1—schizophrenia	0.000477	0.057	CrCbGaD
Ergotamine—HTR1D—midbrain—schizophrenia	0.000472	0.00541	CbGeAlD
Ergotamine—HTR2C—midbrain—schizophrenia	0.000468	0.00536	CbGeAlD
Ergotamine—SLC6A2—gonad—schizophrenia	0.000454	0.0052	CbGeAlD
Ergotamine—Methysergide—HTR6—schizophrenia	0.000446	0.0534	CrCbGaD
Ergotamine—HTR2B—blood—schizophrenia	0.000445	0.0051	CbGeAlD
Ergotamine—HTR1B—endocrine gland—schizophrenia	0.000428	0.00491	CbGeAlD
Ergotamine—ABCB1—blood plasma—schizophrenia	0.000425	0.00487	CbGeAlD
Ergotamine—ADRA2A—forebrain—schizophrenia	0.000418	0.00479	CbGeAlD
Ergotamine—ADRA1B—brain—schizophrenia	0.000406	0.00465	CbGeAlD
Ergotamine—HTR1B—nervous system—schizophrenia	0.000401	0.0046	CbGeAlD
Ergotamine—ADRA1D—brain—schizophrenia	0.000397	0.00455	CbGeAlD
Ergotamine—HTR1A—midbrain—schizophrenia	0.000394	0.00451	CbGeAlD
Ergotamine—HTR1D—nervous system—schizophrenia	0.000388	0.00445	CbGeAlD
Ergotamine—HTR1B—central nervous system—schizophrenia	0.000386	0.00443	CbGeAlD
Ergotamine—HTR2C—nervous system—schizophrenia	0.000384	0.00441	CbGeAlD
Ergotamine—ADRA2A—telencephalon—schizophrenia	0.000384	0.0044	CbGeAlD
Ergotamine—Dihydroergotamine—HTR1B—schizophrenia	0.000379	0.0453	CrCbGaD
Ergotamine—HTR1D—central nervous system—schizophrenia	0.000374	0.00428	CbGeAlD
Ergotamine—HTR2C—central nervous system—schizophrenia	0.00037	0.00424	CbGeAlD
Ergotamine—ADRA1A—blood—schizophrenia	0.000367	0.00421	CbGeAlD
Ergotamine—HTR2B—nervous system—schizophrenia	0.000361	0.00414	CbGeAlD
Ergotamine—DRD2—midbrain—schizophrenia	0.000356	0.00408	CbGeAlD
Ergotamine—HTR2A—forebrain—schizophrenia	0.000355	0.00407	CbGeAlD
Ergotamine—HTR2B—central nervous system—schizophrenia	0.000348	0.00399	CbGeAlD
Ergotamine—HTR1A—endocrine gland—schizophrenia	0.000346	0.00396	CbGeAlD
Ergotamine—SLC6A2—endocrine gland—schizophrenia	0.000343	0.00393	CbGeAlD
Ergotamine—Ergoloid mesylate—DRD2—schizophrenia	0.000336	0.0402	CrCbGaD
Ergotamine—Bromocriptine—HTR6—schizophrenia	0.000332	0.0397	CrCbGaD
Ergotamine—HTR2A—telencephalon—schizophrenia	0.000327	0.00374	CbGeAlD
Ergotamine—HTR1A—nervous system—schizophrenia	0.000324	0.00371	CbGeAlD
Ergotamine—SLC6A2—nervous system—schizophrenia	0.000321	0.00368	CbGeAlD
Ergotamine—ADRA2A—gonad—schizophrenia	0.000321	0.00368	CbGeAlD
Ergotamine—ADRA1A—endocrine gland—schizophrenia	0.000319	0.00365	CbGeAlD
Ergotamine—DRD2—endocrine gland—schizophrenia	0.000312	0.00358	CbGeAlD
Ergotamine—HTR1A—central nervous system—schizophrenia	0.000312	0.00357	CbGeAlD
Ergotamine—SLC6A2—central nervous system—schizophrenia	0.000309	0.00354	CbGeAlD
Ergotamine—HTR1B—brain—schizophrenia	0.000307	0.00351	CbGeAlD
Ergotamine—HTR1A—cerebellum—schizophrenia	0.000305	0.00349	CbGeAlD
Ergotamine—CYP1A2—blood—schizophrenia	0.000304	0.00348	CbGeAlD
Ergotamine—Dihydroergotamine—HTR1A—schizophrenia	0.0003	0.0359	CrCbGaD
Ergotamine—ADRA1A—nervous system—schizophrenia	0.000298	0.00342	CbGeAlD
Ergotamine—HTR1D—brain—schizophrenia	0.000297	0.0034	CbGeAlD
Ergotamine—HTR2C—brain—schizophrenia	0.000294	0.00337	CbGeAlD
Ergotamine—DRD2—nervous system—schizophrenia	0.000292	0.00335	CbGeAlD
Ergotamine—Methylergometrine—DRD1—schizophrenia	0.000289	0.0345	CrCbGaD
Ergotamine—ADRA1A—central nervous system—schizophrenia	0.000287	0.00329	CbGeAlD
Ergotamine—Ergonovine—HTR2C—schizophrenia	0.000283	0.0338	CrCbGaD
Ergotamine—DRD2—central nervous system—schizophrenia	0.000282	0.00323	CbGeAlD
Ergotamine—ADRA1A—cerebellum—schizophrenia	0.000281	0.00322	CbGeAlD
Ergotamine—ADRA2A—blood—schizophrenia	0.000279	0.0032	CbGeAlD
Ergotamine—HTR2B—brain—schizophrenia	0.000276	0.00316	CbGeAlD
Ergotamine—ADRA2A—midbrain—schizophrenia	0.000276	0.00316	CbGeAlD
Ergotamine—DRD2—cerebellum—schizophrenia	0.000275	0.00315	CbGeAlD
Ergotamine—HTR2A—gonad—schizophrenia	0.000273	0.00312	CbGeAlD
Ergotamine—CYP1A2—endocrine gland—schizophrenia	0.000264	0.00302	CbGeAlD
Ergotamine—Methysergide—HTR7—schizophrenia	0.000261	0.0312	CrCbGaD
Ergotamine—Methysergide—HTR1B—schizophrenia	0.000253	0.0302	CrCbGaD
Ergotamine—HTR1A—brain—schizophrenia	0.000247	0.00284	CbGeAlD
Ergotamine—Methylergometrine—HTR2C—schizophrenia	0.000247	0.0295	CrCbGaD
Ergotamine—SLC6A2—brain—schizophrenia	0.000245	0.00281	CbGeAlD
Ergotamine—ADRA2A—endocrine gland—schizophrenia	0.000242	0.00278	CbGeAlD
Ergotamine—HTR2A—blood—schizophrenia	0.000238	0.00272	CbGeAlD
Ergotamine—HTR2A—midbrain—schizophrenia	0.000235	0.00269	CbGeAlD
Ergotamine—ABCB1—forebrain—schizophrenia	0.000233	0.00267	CbGeAlD
Ergotamine—Lisuride—DRD4—schizophrenia	0.000229	0.0274	CrCbGaD
Ergotamine—ADRA1A—brain—schizophrenia	0.000228	0.00261	CbGeAlD
Ergotamine—ADRA2A—nervous system—schizophrenia	0.000227	0.0026	CbGeAlD
Ergotamine—DRD2—brain—schizophrenia	0.000224	0.00256	CbGeAlD
Ergotamine—CYP3A4—blood—schizophrenia	0.00022	0.00252	CbGeAlD
Ergotamine—ADRA2A—central nervous system—schizophrenia	0.000218	0.0025	CbGeAlD
Ergotamine—ABCB1—telencephalon—schizophrenia	0.000214	0.00245	CbGeAlD
Ergotamine—ADRA2A—cerebellum—schizophrenia	0.000213	0.00245	CbGeAlD
Ergotamine—Bromocriptine—DRD4—schizophrenia	0.000212	0.0253	CrCbGaD
Ergotamine—Methysergide—HTR2C—schizophrenia	0.000206	0.0246	CrCbGaD
Ergotamine—HTR2A—endocrine gland—schizophrenia	0.000206	0.00236	CbGeAlD
Ergotamine—Lisuride—HTR1B—schizophrenia	0.000203	0.0243	CrCbGaD
Ergotamine—Methysergide—HTR1A—schizophrenia	0.0002	0.0239	CrCbGaD
Ergotamine—Lisuride—DRD3—schizophrenia	0.000197	0.0236	CrCbGaD
Ergotamine—Bromocriptine—HTR7—schizophrenia	0.000195	0.0232	CrCbGaD
Ergotamine—Lisuride—DRD1—schizophrenia	0.000194	0.0232	CrCbGaD
Ergotamine—HTR2A—nervous system—schizophrenia	0.000193	0.00221	CbGeAlD
Ergotamine—CYP3A4—endocrine gland—schizophrenia	0.000191	0.00219	CbGeAlD
Ergotamine—Bromocriptine—HTR1B—schizophrenia	0.000188	0.0225	CrCbGaD
Ergotamine—HTR2A—central nervous system—schizophrenia	0.000186	0.00213	CbGeAlD
Ergotamine—Bromocriptine—DRD3—schizophrenia	0.000183	0.0219	CrCbGaD
Ergotamine—HTR2A—cerebellum—schizophrenia	0.000181	0.00208	CbGeAlD
Ergotamine—Bromocriptine—DRD1—schizophrenia	0.00018	0.0215	CrCbGaD
Ergotamine—ABCB1—gonad—schizophrenia	0.000179	0.00205	CbGeAlD
Ergotamine—CYP3A4—nervous system—schizophrenia	0.000179	0.00205	CbGeAlD
Ergotamine—ADRA2A—brain—schizophrenia	0.000173	0.00199	CbGeAlD
Ergotamine—CYP3A4—central nervous system—schizophrenia	0.000172	0.00197	CbGeAlD
Ergotamine—Lisuride—HTR2C—schizophrenia	0.000166	0.0198	CrCbGaD
Ergotamine—Lisuride—HTR1A—schizophrenia	0.000161	0.0192	CrCbGaD
Ergotamine—Methylergometrine—HTR2A—schizophrenia	0.000157	0.0188	CrCbGaD
Ergotamine—ABCB1—blood—schizophrenia	0.000156	0.00178	CbGeAlD
Ergotamine—ABCB1—midbrain—schizophrenia	0.000154	0.00176	CbGeAlD
Ergotamine—Bromocriptine—HTR2C—schizophrenia	0.000154	0.0184	CrCbGaD
Ergotamine—Bromocriptine—HTR1A—schizophrenia	0.000149	0.0178	CrCbGaD
Ergotamine—HTR2A—brain—schizophrenia	0.000147	0.00169	CbGeAlD
Ergotamine—Lisuride—DRD2—schizophrenia	0.000137	0.0163	CrCbGaD
Ergotamine—ABCB1—endocrine gland—schizophrenia	0.000135	0.00155	CbGeAlD
Ergotamine—Methysergide—HTR2A—schizophrenia	0.000131	0.0157	CrCbGaD
Ergotamine—Dihydroergotamine—ABCB1—schizophrenia	0.000129	0.0154	CrCbGaD
Ergotamine—Bromocriptine—DRD2—schizophrenia	0.000127	0.0151	CrCbGaD
Ergotamine—ABCB1—nervous system—schizophrenia	0.000126	0.00145	CbGeAlD
Ergotamine—ABCB1—central nervous system—schizophrenia	0.000122	0.00139	CbGeAlD
Ergotamine—ABCB1—cerebellum—schizophrenia	0.000119	0.00136	CbGeAlD
Ergotamine—Ergonovine—ABCB1—schizophrenia	0.000118	0.0141	CrCbGaD
Ergotamine—Bromocriptine—CYP1A2—schizophrenia	0.000116	0.0138	CrCbGaD
Ergotamine—Lisuride—HTR2A—schizophrenia	0.000106	0.0126	CrCbGaD
Ergotamine—Bromocriptine—HTR2A—schizophrenia	9.78e-05	0.0117	CrCbGaD
Ergotamine—ABCB1—brain—schizophrenia	9.66e-05	0.00111	CbGeAlD
Ergotamine—Lisuride—CYP2D6—schizophrenia	9.65e-05	0.0115	CrCbGaD
Ergotamine—Bromocriptine—ABCB1—schizophrenia	6.39e-05	0.00763	CrCbGaD
Ergotamine—ADRA2A—Metabolism—COMT—schizophrenia	4.48e-06	2.57e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—schizophrenia	4.47e-06	2.56e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GSTP1—schizophrenia	4.46e-06	2.56e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—MAOA—schizophrenia	4.45e-06	2.55e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CNR1—schizophrenia	4.44e-06	2.55e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NRG1—schizophrenia	4.43e-06	2.54e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HTR2A—schizophrenia	4.42e-06	2.54e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—APOE—schizophrenia	4.42e-06	2.54e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ERBB4—schizophrenia	4.41e-06	2.53e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PRL—schizophrenia	4.4e-06	2.52e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MEF2C—schizophrenia	4.39e-06	2.52e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—AKT1—schizophrenia	4.38e-06	2.52e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—APOA1—schizophrenia	4.37e-06	2.51e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PLA2G4A—schizophrenia	4.36e-06	2.5e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	4.33e-06	2.49e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HTR7—schizophrenia	4.33e-06	2.48e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—DRD2—schizophrenia	4.33e-06	2.48e-05	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.31e-06	2.48e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—EP300—schizophrenia	4.28e-06	2.46e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NRG1—schizophrenia	4.28e-06	2.46e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NRG1—schizophrenia	4.25e-06	2.44e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—S100B—schizophrenia	4.25e-06	2.44e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—YWHAZ—schizophrenia	4.24e-06	2.44e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MEF2C—schizophrenia	4.24e-06	2.43e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GAPDH—schizophrenia	4.22e-06	2.43e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ESR1—schizophrenia	4.22e-06	2.42e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ABCB1—schizophrenia	4.22e-06	2.42e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MEF2C—schizophrenia	4.22e-06	2.42e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CLOCK—schizophrenia	4.19e-06	2.4e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—S100B—schizophrenia	4.19e-06	2.4e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.18e-06	2.4e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—GSK3B—schizophrenia	4.16e-06	2.39e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TPH1—schizophrenia	4.15e-06	2.39e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GCLM—schizophrenia	4.15e-06	2.39e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ERBB3—schizophrenia	4.15e-06	2.38e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PLA2G4A—schizophrenia	4.15e-06	2.38e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—AKT1—schizophrenia	4.13e-06	2.37e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	4.13e-06	2.37e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—APOE—schizophrenia	4.11e-06	2.36e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—S100B—schizophrenia	4.1e-06	2.35e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—YWHAZ—schizophrenia	4.1e-06	2.35e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PLA2G4A—schizophrenia	4.1e-06	2.35e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GSTM1—schizophrenia	4.1e-06	2.35e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PRL—schizophrenia	4.09e-06	2.35e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SNAP25—schizophrenia	4.09e-06	2.35e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CYP2D6—schizophrenia	4.09e-06	2.35e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TPH2—schizophrenia	4.08e-06	2.34e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CACNB2—schizophrenia	4.08e-06	2.34e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—GSK3B—schizophrenia	4.08e-06	2.34e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	4.08e-06	2.34e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NRG1—schizophrenia	4.07e-06	2.34e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ERBB4—schizophrenia	4.07e-06	2.34e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—APOA1—schizophrenia	4.07e-06	2.33e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EP300—schizophrenia	4.04e-06	2.32e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MEF2C—schizophrenia	4.04e-06	2.32e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—DPYD—schizophrenia	4.01e-06	2.3e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ERBB3—schizophrenia	4.01e-06	2.3e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ERBB4—schizophrenia	4e-06	2.3e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HTR2A—schizophrenia	3.99e-06	2.29e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ERBB3—schizophrenia	3.99e-06	2.29e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ESR1—schizophrenia	3.93e-06	2.25e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ERBB4—schizophrenia	3.92e-06	2.25e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PRKD1—schizophrenia	3.91e-06	2.24e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—YWHAZ—schizophrenia	3.9e-06	2.24e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HTR2A—schizophrenia	3.86e-06	2.21e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HTR2A—schizophrenia	3.84e-06	2.2e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—GSK3B—schizophrenia	3.83e-06	2.2e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	3.83e-06	2.2e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ERBB3—schizophrenia	3.82e-06	2.19e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—S100B—schizophrenia	3.81e-06	2.19e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—AKT1—schizophrenia	3.77e-06	2.17e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	3.76e-06	2.16e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NRG1—schizophrenia	3.75e-06	2.16e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CACNA1C—schizophrenia	3.73e-06	2.14e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MEF2C—schizophrenia	3.72e-06	2.14e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—APOE—schizophrenia	3.71e-06	2.13e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CYP1A2—schizophrenia	3.69e-06	2.12e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NRG1—schizophrenia	3.69e-06	2.12e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PLA2G4A—schizophrenia	3.69e-06	2.12e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HTR2A—schizophrenia	3.67e-06	2.11e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—APOA1—schizophrenia	3.67e-06	2.11e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MEF2C—schizophrenia	3.66e-06	2.1e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ERBB4—schizophrenia	3.64e-06	2.09e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—TH—schizophrenia	3.64e-06	2.09e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3C2A—schizophrenia	3.64e-06	2.09e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—MTHFR—schizophrenia	3.62e-06	2.08e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NRG1—schizophrenia	3.62e-06	2.08e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—YWHAZ—schizophrenia	3.6e-06	2.06e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MEF2C—schizophrenia	3.59e-06	2.06e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APOE—schizophrenia	3.58e-06	2.06e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APOE—schizophrenia	3.57e-06	2.05e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—GSK3B—schizophrenia	3.56e-06	2.04e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ESR1—schizophrenia	3.55e-06	2.04e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APOA1—schizophrenia	3.54e-06	2.03e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	3.54e-06	2.03e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APOA1—schizophrenia	3.53e-06	2.02e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ERBB3—schizophrenia	3.52e-06	2.02e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—YWHAZ—schizophrenia	3.47e-06	1.99e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ERBB3—schizophrenia	3.46e-06	1.99e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PLA2G4A—schizophrenia	3.42e-06	1.97e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ESR1—schizophrenia	3.42e-06	1.96e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOE—schizophrenia	3.41e-06	1.96e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ESR1—schizophrenia	3.4e-06	1.95e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—schizophrenia	3.39e-06	1.95e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ERBB3—schizophrenia	3.39e-06	1.95e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HTR2A—schizophrenia	3.39e-06	1.94e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOA1—schizophrenia	3.37e-06	1.94e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOE—schizophrenia	3.37e-06	1.93e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NRG1—schizophrenia	3.36e-06	1.93e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MEF2C—schizophrenia	3.33e-06	1.91e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOA1—schizophrenia	3.33e-06	1.91e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HTR2A—schizophrenia	3.26e-06	1.87e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP2D6—schizophrenia	3.26e-06	1.87e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SNAP25—schizophrenia	3.26e-06	1.87e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GAPDH—schizophrenia	3.26e-06	1.87e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ESR1—schizophrenia	3.26e-06	1.87e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CLOCK—schizophrenia	3.23e-06	1.85e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—YWHAZ—schizophrenia	3.22e-06	1.85e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—GSK3B—schizophrenia	3.22e-06	1.85e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ERBB3—schizophrenia	3.15e-06	1.81e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TPH2—schizophrenia	3.15e-06	1.81e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CACNB2—schizophrenia	3.15e-06	1.81e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOE—schizophrenia	3.15e-06	1.81e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOA1—schizophrenia	3.11e-06	1.79e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—GSK3B—schizophrenia	3.1e-06	1.78e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—DPYD—schizophrenia	3.1e-06	1.78e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOE—schizophrenia	3.1e-06	1.78e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—COMT—schizophrenia	3.1e-06	1.78e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—GSK3B—schizophrenia	3.09e-06	1.77e-05	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—schizophrenia	3.09e-06	1.77e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GSTP1—schizophrenia	3.08e-06	1.77e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MAOA—schizophrenia	3.07e-06	1.76e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—schizophrenia	3.06e-06	1.76e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOA1—schizophrenia	3.06e-06	1.76e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOE—schizophrenia	3.03e-06	1.74e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HTR2A—schizophrenia	3.03e-06	1.74e-05	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—schizophrenia	3.02e-06	1.73e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ESR1—schizophrenia	3e-06	1.73e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOA1—schizophrenia	3e-06	1.72e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ESR1—schizophrenia	2.96e-06	1.7e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GSK3B—schizophrenia	2.96e-06	1.7e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TH—schizophrenia	2.91e-06	1.67e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ESR1—schizophrenia	2.9e-06	1.66e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—schizophrenia	2.89e-06	1.66e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CACNA1C—schizophrenia	2.88e-06	1.65e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—schizophrenia	2.86e-06	1.64e-05	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—schizophrenia	2.84e-06	1.63e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PLA2G4A—schizophrenia	2.83e-06	1.63e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GSTM1—schizophrenia	2.83e-06	1.63e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOE—schizophrenia	2.82e-06	1.62e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3C2A—schizophrenia	2.81e-06	1.61e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—schizophrenia	2.8e-06	1.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOA1—schizophrenia	2.79e-06	1.6e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—schizophrenia	2.74e-06	1.57e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EP300—schizophrenia	2.74e-06	1.57e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GSK3B—schizophrenia	2.73e-06	1.56e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ESR1—schizophrenia	2.69e-06	1.54e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GSK3B—schizophrenia	2.68e-06	1.54e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EP300—schizophrenia	2.68e-06	1.54e-05	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—schizophrenia	2.64e-06	1.52e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GSK3B—schizophrenia	2.63e-06	1.51e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—schizophrenia	2.59e-06	1.49e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—schizophrenia	2.58e-06	1.48e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EP300—schizophrenia	2.52e-06	1.45e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.52e-06	1.45e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SNAP25—schizophrenia	2.52e-06	1.45e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—schizophrenia	2.5e-06	1.44e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—COMT—schizophrenia	2.47e-06	1.42e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GSTP1—schizophrenia	2.46e-06	1.41e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MAOA—schizophrenia	2.45e-06	1.41e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—schizophrenia	2.44e-06	1.4e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GSK3B—schizophrenia	2.44e-06	1.4e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—schizophrenia	2.4e-06	1.38e-05	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—schizophrenia	2.38e-06	1.37e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.38e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EP300—schizophrenia	2.34e-06	1.35e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—schizophrenia	2.33e-06	1.34e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCB1—schizophrenia	2.33e-06	1.34e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOA1—schizophrenia	2.3e-06	1.32e-05	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—schizophrenia	2.3e-06	1.32e-05	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	2.29e-06	1.31e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.28e-06	1.31e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PLA2G4A—schizophrenia	2.26e-06	1.3e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GSTM1—schizophrenia	2.26e-06	1.3e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TH—schizophrenia	2.24e-06	1.29e-05	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—schizophrenia	2.19e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—schizophrenia	2.16e-06	1.24e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EP300—schizophrenia	2.12e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—schizophrenia	2.09e-06	1.2e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—schizophrenia	2.08e-06	1.19e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EP300—schizophrenia	2.04e-06	1.17e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EP300—schizophrenia	2.03e-06	1.17e-05	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—schizophrenia	2.02e-06	1.16e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—schizophrenia	2e-06	1.15e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—schizophrenia	1.99e-06	1.14e-05	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	1.99e-06	1.14e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—schizophrenia	1.96e-06	1.13e-05	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—schizophrenia	1.95e-06	1.12e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EP300—schizophrenia	1.95e-06	1.12e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—EP300—schizophrenia	1.92e-06	1.1e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—schizophrenia	1.92e-06	1.1e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—COMT—schizophrenia	1.91e-06	1.1e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GSTP1—schizophrenia	1.9e-06	1.09e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MAOA—schizophrenia	1.89e-06	1.09e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—schizophrenia	1.86e-06	1.07e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOA1—schizophrenia	1.84e-06	1.06e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—schizophrenia	1.83e-06	1.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—schizophrenia	1.81e-06	1.04e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—schizophrenia	1.81e-06	1.04e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—schizophrenia	1.8e-06	1.03e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCB1—schizophrenia	1.8e-06	1.03e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EP300—schizophrenia	1.79e-06	1.03e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—schizophrenia	1.77e-06	1.01e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EP300—schizophrenia	1.76e-06	1.01e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.74e-06	1e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GSTM1—schizophrenia	1.74e-06	1e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EP300—schizophrenia	1.73e-06	9.92e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—schizophrenia	1.68e-06	9.63e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—schizophrenia	1.66e-06	9.5e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—schizophrenia	1.64e-06	9.43e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—schizophrenia	1.62e-06	9.3e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EP300—schizophrenia	1.61e-06	9.22e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—schizophrenia	1.54e-06	8.85e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—schizophrenia	1.52e-06	8.74e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—schizophrenia	1.51e-06	8.69e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—schizophrenia	1.46e-06	8.39e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—schizophrenia	1.45e-06	8.35e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—schizophrenia	1.44e-06	8.24e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOA1—schizophrenia	1.42e-06	8.15e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—schizophrenia	1.42e-06	8.13e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—schizophrenia	1.39e-06	7.99e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—EP300—schizophrenia	1.33e-06	7.62e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—schizophrenia	1.28e-06	7.37e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—schizophrenia	1.28e-06	7.34e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—schizophrenia	1.26e-06	7.25e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—schizophrenia	1.24e-06	7.1e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—schizophrenia	1.23e-06	7.09e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—schizophrenia	1.23e-06	7.05e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—schizophrenia	1.18e-06	6.75e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—schizophrenia	1.16e-06	6.66e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—schizophrenia	1.15e-06	6.6e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—schizophrenia	1.08e-06	6.22e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—schizophrenia	1.07e-06	6.12e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—EP300—schizophrenia	1.06e-06	6.09e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—schizophrenia	1.04e-06	6e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—schizophrenia	9.7e-07	5.57e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—EP300—schizophrenia	8.18e-07	4.7e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—schizophrenia	8.02e-07	4.61e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—schizophrenia	6.41e-07	3.68e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—schizophrenia	4.94e-07	2.84e-06	CbGpPWpGaD
